These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12105163)

  • 21. Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study.
    Gerdts E; Okin PM; Omvik P; Wachtell K; Dahlöf B; Hildebrandt P; Nieminen MS; Devereux RB
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):306-12. PubMed ID: 19303268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited contribution of left ventricular mass and remodelling to the impact of blood pressure on diastolic function in a community sample.
    Bamaiyi AJ; Norton GR; Peterson V; Libhaber CD; Sareli P; Woodiwiss AJ
    J Hypertens; 2019 Jun; 37(6):1191-1199. PubMed ID: 31026244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
    Mayet J; Ariff B; Wasan B; Chapman N; Shahi M; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 2000 Nov; 36(5):755-9. PubMed ID: 11082139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
    Gerdts E; Zabalgoitia M; Björnstad H; Svendsen TL; Devereux RB
    Am J Cardiol; 2001 Apr; 87(8):980-3; A4. PubMed ID: 11305990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Li ZB; Wachtell K; Okin PM; Gerdts E; Liu JE; Nieminen MS; Jern S; Dahlöf B; Devereux RB
    J Hum Hypertens; 2004 Jun; 18(6):397-402. PubMed ID: 15071485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in components of left ventricular mechanics under selective beta-1 blockade: insight from traditional and new technologies in echocardiography.
    Palmieri V; Russo C; Palmieri EA; Pezzullo S; Celentano A
    Eur J Echocardiogr; 2009 Aug; 10(6):745-52. PubMed ID: 19465587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
    Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
    Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
    Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
    Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
    J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
    Biederman RW; Doyle M; Young AA; Devereux RB; Kortright E; Perry G; Bella JN; Oparil S; Calhoun D; Pohost GM; Dell'Italia LJ
    Hypertension; 2008 Aug; 52(2):279-86. PubMed ID: 18606908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study.
    de Simone G; Kitzman DW; Palmieri V; Liu JE; Oberman A; Hopkins PN; Bella JN; Rao DC; Arnett DK; Devereux RB
    Am J Hypertens; 2004 Sep; 17(9):828-33. PubMed ID: 15363827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure.
    Schillaci G; Verdecchia P; Reboldi G; Pede S; Porcellati C
    Am J Cardiol; 2000 Sep; 86(5):509-13. PubMed ID: 11009267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative wall thickness is an independent predictor of left ventricular systolic and diastolic dysfunctions in essential hypertension.
    Li L; Shigematsu Y; Hamada M; Hiwada K
    Hypertens Res; 2001 Sep; 24(5):493-9. PubMed ID: 11675942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study).
    Gerdts E; Franklin S; Rieck A; Papademetriou V; Wachtell K; Nieminen M; Dahlöf B; Devereux RB
    Blood Press; 2009; 18(4):180-6. PubMed ID: 19562573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging.
    Onose Y; Oki T; Yamada H; Manabe K; Kageji Y; Matsuoka M; Yamamoto T; Tabata T; Wakatsuki T; Ito S
    Jpn Circ J; 2001 Apr; 65(4):305-9. PubMed ID: 11316128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function.
    Devereux RB; de Simone G; Pickering TG; Schwartz JE; Roman MJ
    Hypertension; 1998 Apr; 31(4):929-36. PubMed ID: 9535417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular mass and systolic dysfunction in essential hypertension.
    Schillaci G; Vaudo G; Pasqualini L; Reboldi G; Porcellati C; Verdecchia P
    J Hum Hypertens; 2002 Feb; 16(2):117-22. PubMed ID: 11850769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.